{"id":"https://openalex.org/W2016149155","doi":"https://doi.org/10.1097/wnf.0b013e318204cd90","title":"Cladribine: Mode of Action and Implications for Treatment of Multiple Sclerosis","display_name":"Cladribine: Mode of Action and Implications for Treatment of Multiple Sclerosis","alternate_titles":[],"publication_year":2011,"publication_date":"2011-01-01","ids":{"openalex":"https://openalex.org/W2016149155","doi":"https://doi.org/10.1097/wnf.0b013e318204cd90","mag":"2016149155","pmid":"https://pubmed.ncbi.nlm.nih.gov/21242742"},"language":"en","primary_location":{"id":"doi:10.1097/wnf.0b013e318204cd90","doi":"https://doi.org/10.1097/wnf.0b013e318204cd90","is_oa":false,"landing_page_url":"https://doi.org/10.1097/wnf.0b013e318204cd90","pdf_url":null,"source":{"id":"https://openalex.org/S3349026","display_name":"Clinical Neuropharmacology","issn_l":"0362-5664","issn":["0362-5664","1537-162X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Neuropharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2016149155"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002866949","display_name":"Thomas P. Leist","orcid":"https://orcid.org/0000-0002-8924-8891","observed_orcids":["https://orcid.org/0000-0002-8924-8891"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Thomas P. Leist","raw_affiliation_strings":["Thomas Jefferson University, Philadelphia, PA, USA","Thomas Jefferson University, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thomas Jefferson University, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I149251103"]},{"raw_affiliation_string":"Thomas Jefferson University, Philadelphia, PA","institution_ids":["https://openalex.org/I149251103"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044690856","display_name":"Robert Weissert","orcid":"https://orcid.org/0000-0002-1295-1271","observed_orcids":["https://orcid.org/0000-0002-1295-1271"]},"institutions":[{"id":"https://openalex.org/I4210106256","display_name":"University Hospital of Geneva","ror":"https://ror.org/01m1pv723","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I4210106256"]},{"id":"https://openalex.org/I4210113211","display_name":"Merck Serono S.A. (Switzerland)","ror":"https://ror.org/01vp49361","country_code":"CH","type":"company","lineage":["https://openalex.org/I164928964","https://openalex.org/I4210113211"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Robert Weissert","raw_affiliation_strings":["Department of Neurology, Geneva University Hospital, Geneva, Switzerland","Merck Serono S.A. - Geneva"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Geneva University Hospital, Geneva, Switzerland","institution_ids":["https://openalex.org/I4210106256"]},{"raw_affiliation_string":"Merck Serono S.A. - Geneva","institution_ids":["https://openalex.org/I4210113211"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5002866949"],"corresponding_institution_ids":["https://openalex.org/I149251103"],"apc_list":null,"apc_paid":null,"fwci":0.8607,"has_fulltext":false,"cited_by_count":227,"citation_normalized_percentile":{"value":0.61293532,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"34","issue":"1","first_page":"28","last_page":"35"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cladribine","display_name":"cladribine","score":1.0},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9829999804496765},{"id":"https://openalex.org/keywords/relapsing-remitting-multiple-sclerosis","display_name":"relapsing-remitting multiple sclerosis","score":0.984000027179718},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.6809999942779541},{"id":"https://openalex.org/keywords/deoxycytidine-kinase","display_name":"deoxycytidine kinase","score":0.8019999861717224},{"id":"https://openalex.org/keywords/dna-synthesis-inhibition","display_name":"DNA synthesis inhibition","score":0.6439999938011169},{"id":"https://openalex.org/keywords/dna-strand-breaks","display_name":"DNA strand breaks","score":0.6200000047683716},{"id":"https://openalex.org/keywords/lymphodepletion","display_name":"lymphocyte depletion","score":0.7300000190734863},{"id":"https://openalex.org/keywords/demyelination","display_name":"demyelination","score":0.7730000019073486},{"id":"https://openalex.org/keywords/clarity-trial","display_name":"CLARITY trial","score":0.8550000190734863},{"id":"https://openalex.org/keywords/neuroimaging-findings","display_name":"neuroimaging findings","score":0.6029999852180481}],"concepts":[{"id":"https://openalex.org/C2779200787","wikidata":"https://www.wikidata.org/wiki/Q414030","display_name":"Cladribine","level":2,"score":0.994463324546814},{"id":"https://openalex.org/C2779268695","wikidata":"https://www.wikidata.org/wiki/Q14914175","display_name":"Deoxycytidine kinase","level":5,"score":0.7575244903564453},{"id":"https://openalex.org/C4710235","wikidata":"https://www.wikidata.org/wiki/Q420089","display_name":"Ribonucleotide reductase","level":4,"score":0.7392756938934326},{"id":"https://openalex.org/C2780636463","wikidata":"https://www.wikidata.org/wiki/Q422457","display_name":"Deoxyadenosine","level":3,"score":0.5233401656150818},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.43611282110214233},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.432582288980484},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4237544536590576},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.41696101427078247},{"id":"https://openalex.org/C2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","level":2,"score":0.41456252336502075},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3783529996871948},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3762430250644684},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.373165488243103},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35874587297439575},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.33643728494644165},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.29881536960601807},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.25792694091796875},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15460532903671265},{"id":"https://openalex.org/C2777844706","wikidata":"https://www.wikidata.org/wiki/Q422504","display_name":"Deoxycytidine","level":4,"score":0.12166628241539001},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.11244922876358032},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.08997204899787903},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.06481513381004333},{"id":"https://openalex.org/C104292427","wikidata":"https://www.wikidata.org/wiki/Q899781","display_name":"Protein subunit","level":3,"score":0.0},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.0},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008214","descriptor_name":"Lymphocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009103","descriptor_name":"Multiple Sclerosis","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017338","descriptor_name":"Cladribine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/wnf.0b013e318204cd90","doi":"https://doi.org/10.1097/wnf.0b013e318204cd90","is_oa":false,"landing_page_url":"https://doi.org/10.1097/wnf.0b013e318204cd90","pdf_url":null,"source":{"id":"https://openalex.org/S3349026","display_name":"Clinical Neuropharmacology","issn_l":"0362-5664","issn":["0362-5664","1537-162X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Neuropharmacology","raw_type":"journal-article"},{"id":"pmid:21242742","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21242742","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical neuropharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320311647","display_name":"Merck KGaA","ror":"https://ror.org/04b2dty93"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":72,"referenced_works":["https://openalex.org/W108562724","https://openalex.org/W167367971","https://openalex.org/W218420279","https://openalex.org/W1507320147","https://openalex.org/W1550823327","https://openalex.org/W1566384842","https://openalex.org/W1872188472","https://openalex.org/W1964298852","https://openalex.org/W1966560563","https://openalex.org/W1974697153","https://openalex.org/W1976268183","https://openalex.org/W1978427676","https://openalex.org/W1981220317","https://openalex.org/W1983066514","https://openalex.org/W1983494190","https://openalex.org/W1986195187","https://openalex.org/W1995570857","https://openalex.org/W1996325159","https://openalex.org/W2001633613","https://openalex.org/W2003048901","https://openalex.org/W2004545336","https://openalex.org/W2008060191","https://openalex.org/W2021623849","https://openalex.org/W2033175786","https://openalex.org/W2035766348","https://openalex.org/W2038860593","https://openalex.org/W2042960601","https://openalex.org/W2045762174","https://openalex.org/W2047200592","https://openalex.org/W2048417169","https://openalex.org/W2061372490","https://openalex.org/W2063711494","https://openalex.org/W2064816281","https://openalex.org/W2065431319","https://openalex.org/W2070487931","https://openalex.org/W2070513259","https://openalex.org/W2070625707","https://openalex.org/W2077421929","https://openalex.org/W2079318223","https://openalex.org/W2080463438","https://openalex.org/W2082470201","https://openalex.org/W2082519456","https://openalex.org/W2103294049","https://openalex.org/W2103758700","https://openalex.org/W2106022925","https://openalex.org/W2110633552","https://openalex.org/W2111480581","https://openalex.org/W2111800376","https://openalex.org/W2113291839","https://openalex.org/W2115128424","https://openalex.org/W2115139696","https://openalex.org/W2116910451","https://openalex.org/W2117535556","https://openalex.org/W2118285512","https://openalex.org/W2119260372","https://openalex.org/W2120679827","https://openalex.org/W2122347714","https://openalex.org/W2124417387","https://openalex.org/W2134885049","https://openalex.org/W2139204856","https://openalex.org/W2147578269","https://openalex.org/W2148584668","https://openalex.org/W2148631447","https://openalex.org/W2158692407","https://openalex.org/W2163089957","https://openalex.org/W2168423102","https://openalex.org/W2250133118","https://openalex.org/W2335263466","https://openalex.org/W2409131906","https://openalex.org/W2461761530","https://openalex.org/W6633212396","https://openalex.org/W6662396653"],"related_works":["https://openalex.org/W1593427168","https://openalex.org/W3216401883","https://openalex.org/W2833295077","https://openalex.org/W3156209709","https://openalex.org/W4281715473","https://openalex.org/W1955491518","https://openalex.org/W1971449315","https://openalex.org/W43053104","https://openalex.org/W2136086233","https://openalex.org/W2088439566"],"abstract_inverted_index":{"Multiple":[0],"sclerosis":[1],"(MS)":[2],"is":[3,15,54,61],"an":[4],"inflammatory":[5],"neurodegenerative":[6],"disease":[7],"of":[8,24,74,84,89,96,107,126,155,157,163,169],"the":[9,25,82,93,153,161,170],"central":[10],"nervous":[11],"system.":[12],"The":[13,86],"inflammation":[14],"driven":[16],"significantly":[17],"by":[18],"autoreactive":[19],"lymphocytes,":[20],"which":[21],"recruit":[22],"cells":[23],"innate":[26],"immune":[27],"system":[28],"such":[29],"as":[30],"macrophages":[31],"that":[32,45,60],"contribute":[33],"to":[34,110,142],"subsequent":[35],"tissue":[36],"damage,":[37],"ultimately":[38,147],"resulting":[39],"in":[40,48,64,81,99,129,139,160,190],"demyelination":[41],"and":[42,68,71,77,117,123,135,146,187],"axonal":[43],"damage":[44],"are":[46],"characteristic":[47],"MS":[49],"lesions.":[50],"Cladribine":[51],"(2-chlorodeoxyadenosine":[52],"[2-CdA])":[53],"a":[55,103],"synthetic":[56],"chlorinated":[57],"deoxyadenosine":[58],"analog":[59],"biologically":[62],"active":[63],"selected":[65],"cell":[66,100,148],"types":[67,101],"provides":[69],"targeted":[70],"sustained":[72],"reduction":[73],"circulating":[75],"T":[76],"B":[78],"lymphocytes":[79],"implicated":[80],"pathogenesis":[83],"MS.":[85,192],"biologic":[87],"activity":[88],"cladribine":[90,97,158,180],"depends":[91],"on":[92,185],"preferential":[94],"accumulation":[95],"phosphates":[98],"with":[102,114],"high":[104],"intracellular":[105],"ratio":[106],"deoxycytidine":[108],"kinase":[109],"5'-nucleotidases.":[111],"Cladribine-phosphates":[112],"interfere":[113],"DNA":[115,122,130,133,143],"synthesis":[116],"repair":[118],"through":[119,124],"incorporation":[120],"into":[121],"inhibition":[125],"enzymes":[127],"involved":[128],"metabolism,":[131],"including":[132],"polymerase":[134],"ribonucleotide":[136],"reductase.":[137],"This":[138,150],"turn":[140],"leads":[141],"strand":[144],"breaks":[145],"death.":[149],"review":[151],"explores":[152],"mechanism":[154],"action":[156],"further,":[159],"context":[162],"recent":[164],"clinical":[165,186],"data,":[166],"after":[167],"completion":[168],"phase":[171],"III,":[172],"96-week,":[173],"placebo-controlled":[174],"CLARITY":[175],"study.":[176],"In":[177],"this":[178],"study,":[179],"tablets":[181],"demonstrated":[182],"significant":[183],"efficacy":[184],"neuroimaging":[188],"outcomes":[189],"relapsing-remitting":[191]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2016149155","counts_by_year":[{"year":2026,"cited_by_count":15},{"year":2025,"cited_by_count":29},{"year":2024,"cited_by_count":30},{"year":2023,"cited_by_count":24},{"year":2022,"cited_by_count":20},{"year":2021,"cited_by_count":20},{"year":2020,"cited_by_count":18},{"year":2019,"cited_by_count":16},{"year":2018,"cited_by_count":22},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
